VolitionRx Limited to Present at Jefferies Global Healthcare Conference
Presentation Details:
Date: Wednesday, June 5, 2024
Time: 3.30 pm ET (Track 3)
Investors can schedule a one-to-one meeting with Volition's Executive Team by emailing investorrelations@volition.com.
About Volition
Volition is a multi-national company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring.
Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help diagnose and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis. Early diagnosis and monitoring have the potential not only to prolong the life of patients, but also improve their quality of life.
Volition's research and development activities are centered in
The contents found at Volition's website address are not incorporated by reference into this document and should not be considered part of this document. Such website address is included in this document as an inactive textual reference only.
Media Enquiries:
View original content:https://www.prnewswire.com/news-releases/volitionrx-limited-to-present-at-jefferies-global-healthcare-conference-302157932.html
SOURCE